Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 6/2016

28.08.2015 | Original Paper

Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia

verfasst von: Hans-Gert Bernstein, Esther Jauch, Henrik Dobrowolny, Christian Mawrin, Johann Steiner, Bernhard Bogerts

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Profound white matter abnormalities have repeatedly been described in schizophrenia, which involve the altered expression of numerous oligodendrocyte-associated genes. Transcripts of the disrupted-in-schizophrenia 1 (DISC1) gene, a key susceptibility factor in schizophrenia, have recently been shown to be expressed by oligodendroglial cells and to negatively regulate oligodendrocyte differentiation and maturation. To learn more about the putative role(s) of oligodendroglia-associated DISC1 in schizophrenia, we analyzed the density of DISC1-immunoreactive oligodendrocytes in the fronto-parietal white matter in postmortem brains of patients with schizophrenia. Compared with controls (N = 12) and cases with undifferentiated/residual schizophrenia (N = 6), there was a significantly increased density of DISC1-expressing glial cells in paranoid schizophrenia (N = 12), which unlikely resulted from neuroleptic treatment. Pathophysiologically, over-expression of DISC1 protein(s) in white matter oligodendrocytes might add to the reduced levels of two myelin markers, 2′,3′-cyclic-nucleotide 3′-phosphodiesterase and myelin basic protein in schizophrenia. Moreover, it might significantly contribute to cell cycle abnormalities as well as to deficits in oligodendroglial cell differentiation and maturation found in schizophrenia.
Literatur
1.
Zurück zum Zitat Bernstein HG, Steiner J, Guest PC, Dobrowolny H, Bogerts B (2015) Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr Res 161:4–18CrossRefPubMed Bernstein HG, Steiner J, Guest PC, Dobrowolny H, Bogerts B (2015) Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr Res 161:4–18CrossRefPubMed
2.
Zurück zum Zitat Griffa A, Baumann PS, Ferrari C, Do KQ, Conus P, Thiran JP, Hagmann P (2015) Characterizing the connectome in schizophrenia with diffusion spectrum imaging. Hum Brain Mapp 36:354–366CrossRefPubMed Griffa A, Baumann PS, Ferrari C, Do KQ, Conus P, Thiran JP, Hagmann P (2015) Characterizing the connectome in schizophrenia with diffusion spectrum imaging. Hum Brain Mapp 36:354–366CrossRefPubMed
3.
Zurück zum Zitat Najjar S, Pearlman DM (2015) Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 16:102–112CrossRef Najjar S, Pearlman DM (2015) Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 16:102–112CrossRef
4.
Zurück zum Zitat Parlapani E, Schmit A, Erdmann A, Bernstein HG, Breunig B, Gruber O, Petroianu G, von Wilmsdorff M, Schneider-Axmann T, Honer W, Falkai P (2009) Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res 1301:126–134CrossRefPubMed Parlapani E, Schmit A, Erdmann A, Bernstein HG, Breunig B, Gruber O, Petroianu G, von Wilmsdorff M, Schneider-Axmann T, Honer W, Falkai P (2009) Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res 1301:126–134CrossRefPubMed
5.
Zurück zum Zitat Schmitt A, Hasan A, Gruber O, Falkai P (2011) Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci Suppl 2:S150–S154CrossRef Schmitt A, Hasan A, Gruber O, Falkai P (2011) Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci Suppl 2:S150–S154CrossRef
6.
Zurück zum Zitat Walterfang M, Velakoulis D, Whitford TJ, Pantelis C (2011) Understanding aberrant white matter development in schizophrenia: an avenue for therapy? Expert Rev Neurother 11:971–987CrossRefPubMed Walterfang M, Velakoulis D, Whitford TJ, Pantelis C (2011) Understanding aberrant white matter development in schizophrenia: an avenue for therapy? Expert Rev Neurother 11:971–987CrossRefPubMed
7.
Zurück zum Zitat Mighdoll MI, Tao R, Kleinman JE, Hyde TM (2015) Myelin, myelin-related disorders, and psychosis. Schizophr Res 161:85–93CrossRefPubMed Mighdoll MI, Tao R, Kleinman JE, Hyde TM (2015) Myelin, myelin-related disorders, and psychosis. Schizophr Res 161:85–93CrossRefPubMed
8.
Zurück zum Zitat Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497:436–450CrossRefPubMed Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497:436–450CrossRefPubMed
9.
Zurück zum Zitat Bertram I, Bernstein HG, Lendeckel U, Bukowska A, Dobrowolny H, Keilhoff G, Kanakis D, Mawrin C, Bielau H, Falkai P, Bogerts B (2007) Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefronta cortex in schizophrenia and in unipolar depression. Ann NY Acad Sci 1096:147–156CrossRefPubMed Bertram I, Bernstein HG, Lendeckel U, Bukowska A, Dobrowolny H, Keilhoff G, Kanakis D, Mawrin C, Bielau H, Falkai P, Bogerts B (2007) Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefronta cortex in schizophrenia and in unipolar depression. Ann NY Acad Sci 1096:147–156CrossRefPubMed
10.
Zurück zum Zitat Kostović I, Judaš M, Sedmak G (2011) Developmental history of the subplate zone, subplate neurons and interstitial white matter neurons: relevance for schizophrenia. Int J Dev Neurosci 29:193–205CrossRefPubMed Kostović I, Judaš M, Sedmak G (2011) Developmental history of the subplate zone, subplate neurons and interstitial white matter neurons: relevance for schizophrenia. Int J Dev Neurosci 29:193–205CrossRefPubMed
11.
Zurück zum Zitat Yang Y, Fung SJ, Rothwell A, Tianmei S, Weickert CS (2011) Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 69:63–70CrossRefPubMed Yang Y, Fung SJ, Rothwell A, Tianmei S, Weickert CS (2011) Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 69:63–70CrossRefPubMed
12.
Zurück zum Zitat Byne W, Kidkardnee S, Tatusov SA, Yiannoulos G, Buchsbaum MS, Haroutunian V (2006) Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res 85:245–253CrossRefPubMed Byne W, Kidkardnee S, Tatusov SA, Yiannoulos G, Buchsbaum MS, Haroutunian V (2006) Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res 85:245–253CrossRefPubMed
13.
Zurück zum Zitat Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD (2002) Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 27:1193–1200CrossRefPubMed Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD (2002) Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 27:1193–1200CrossRefPubMed
14.
Zurück zum Zitat Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, Davis KL (2003) Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075–1085CrossRefPubMed Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, Davis KL (2003) Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075–1085CrossRefPubMed
15.
Zurück zum Zitat Uranova NA, Orlovskaya DD, Vikhreva OV, Zimina IS, Rakhmanova VI (2001) Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestn Ross Akad Med Nauk 7:42–48PubMed Uranova NA, Orlovskaya DD, Vikhreva OV, Zimina IS, Rakhmanova VI (2001) Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestn Ross Akad Med Nauk 7:42–48PubMed
16.
Zurück zum Zitat Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova V (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269–275CrossRefPubMed Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova V (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269–275CrossRefPubMed
17.
Zurück zum Zitat Bernstein HG, Steiner J, Bogerts B (2009) Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 9:1059–1071CrossRefPubMed Bernstein HG, Steiner J, Bogerts B (2009) Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 9:1059–1071CrossRefPubMed
18.
Zurück zum Zitat Bernstein HG, Smalla KH, Dürrschmidt D, Keilhoff G, Dobrowolny H, Steiner J, Schmitt A, Kreutz MR, Bogerts B (2012) Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med 14:270–280CrossRefPubMed Bernstein HG, Smalla KH, Dürrschmidt D, Keilhoff G, Dobrowolny H, Steiner J, Schmitt A, Kreutz MR, Bogerts B (2012) Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med 14:270–280CrossRefPubMed
19.
Zurück zum Zitat Höistad M, Sega D, Takahashi N, Sakurai T, Buxbaum JD, Hof PR (2009) Linking white and grey matter in schizophrenia: oligodendrcyte and neuron pathology in the prefrontal cortex. Front Neuroanat 3:9CrossRefPubMedPubMedCentral Höistad M, Sega D, Takahashi N, Sakurai T, Buxbaum JD, Hof PR (2009) Linking white and grey matter in schizophrenia: oligodendrcyte and neuron pathology in the prefrontal cortex. Front Neuroanat 3:9CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Schmitt A, Steyskal C, Bernstein HG, Schneider-Axmann T, Parlapani E, Schaeffer EL, Gattaz WIF, Bogerts B, Schmitz C, Falkai P (2009) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 117:395–407CrossRefPubMed Schmitt A, Steyskal C, Bernstein HG, Schneider-Axmann T, Parlapani E, Schaeffer EL, Gattaz WIF, Bogerts B, Schmitz C, Falkai P (2009) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 117:395–407CrossRefPubMed
21.
Zurück zum Zitat Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein HG (2010) Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry 11:556–566CrossRefPubMed Farkas N, Lendeckel U, Dobrowolny H, Funke S, Steiner J, Keilhoff G, Schmitt A, Bogerts B, Bernstein HG (2010) Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry 11:556–566CrossRefPubMed
22.
Zurück zum Zitat Vostrikov V, Uranova N (2011) Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treat 2011:174689 Vostrikov V, Uranova N (2011) Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treat 2011:174689
23.
Zurück zum Zitat Miyata S, Hattori T, Shimizu S, Ito A, Tohyama M (2015) Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed Res Int 2015:492367PubMedPubMedCentral Miyata S, Hattori T, Shimizu S, Ito A, Tohyama M (2015) Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed Res Int 2015:492367PubMedPubMedCentral
24.
Zurück zum Zitat Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, St Clair DM, Muir WJ, Blackwood DH, Porteous DJ (2000) Disruption of two novel genes by a transloation co-segregating with schizophrenia. Mol Genet 9:1415–1423 Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, St Clair DM, Muir WJ, Blackwood DH, Porteous DJ (2000) Disruption of two novel genes by a transloation co-segregating with schizophrenia. Mol Genet 9:1415–1423
25.
Zurück zum Zitat Thomson PA, Parla JS, McRae AF, Kramer M, Ramakrishnan K, Yao J, Soares DC, McCarthy S, Morris SW, Cardone L, Cass S, Ghiban E, Hennah W, Evans KL, Rebolini D, Millar JK, Harris SE, Starr JM, MacIntyre DJ, Generation Scotland, McIntosh AM, Watson JD, Deary IJ, Visscher PM, Blackwood DH, McCombie WR, Porteous DJ (2014) 708 common and 2010 rare DISC1 locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits. Mol Psychiatry 19:668–675CrossRefPubMed Thomson PA, Parla JS, McRae AF, Kramer M, Ramakrishnan K, Yao J, Soares DC, McCarthy S, Morris SW, Cardone L, Cass S, Ghiban E, Hennah W, Evans KL, Rebolini D, Millar JK, Harris SE, Starr JM, MacIntyre DJ, Generation Scotland, McIntosh AM, Watson JD, Deary IJ, Visscher PM, Blackwood DH, McCombie WR, Porteous DJ (2014) 708 common and 2010 rare DISC1 locus variants identified in 1542 subjects: analysis for association with psychiatric disorder and cognitive traits. Mol Psychiatry 19:668–675CrossRefPubMed
26.
Zurück zum Zitat Porteous DJ, Millar JK (2006) Disrupted in schizophrenia 1: building brains and memories. Trends Mol Med 12:255–261CrossRefPubMed Porteous DJ, Millar JK (2006) Disrupted in schizophrenia 1: building brains and memories. Trends Mol Med 12:255–261CrossRefPubMed
27.
Zurück zum Zitat Lee SA, Kim SM, Suh BK, Sun HY, Park YU, Hong JH, Park C, Nguyen MD, Nagata K, Yoo JY, Park SK (2015) Disrupted-in-schizophrenia 1 (DISC1) regulates dysbindin function by enhancing its stability. J Biol Chem 290:7087–7096CrossRefPubMedCentral Lee SA, Kim SM, Suh BK, Sun HY, Park YU, Hong JH, Park C, Nguyen MD, Nagata K, Yoo JY, Park SK (2015) Disrupted-in-schizophrenia 1 (DISC1) regulates dysbindin function by enhancing its stability. J Biol Chem 290:7087–7096CrossRefPubMedCentral
28.
Zurück zum Zitat Knickmeyer RC, Wang J, Zhu H, Geng X, Woolson S, Hamer RM, Konneker T, Lin W, Styner M, Gilmore JH (2014) Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 24:1230–1246CrossRefPubMed Knickmeyer RC, Wang J, Zhu H, Geng X, Woolson S, Hamer RM, Konneker T, Lin W, Styner M, Gilmore JH (2014) Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 24:1230–1246CrossRefPubMed
29.
Zurück zum Zitat Brauns S, Gollub RL, Roffman JL, Yendik A, Ho BC, Wassink TH, Heinz A, Ehrlich S (2011) DISC1 is associated with cortical thickness and neural efficiency. Neuroimage 57:1591–1600CrossRefPubMedPubMedCentral Brauns S, Gollub RL, Roffman JL, Yendik A, Ho BC, Wassink TH, Heinz A, Ehrlich S (2011) DISC1 is associated with cortical thickness and neural efficiency. Neuroimage 57:1591–1600CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kirkpatrick B, Messias NC, Conley RR, Roberts RC (2003) Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficient and nondeficient schizophrenia. J Nerv Ment Dis 191:563–567CrossRefPubMed Kirkpatrick B, Messias NC, Conley RR, Roberts RC (2003) Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficient and nondeficient schizophrenia. J Nerv Ment Dis 191:563–567CrossRefPubMed
31.
Zurück zum Zitat Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong P, Korth C, Anton ES, Sawa A (2010) Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci USA 107:5622–5627CrossRefPubMedPubMedCentral Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, Stanco A, Eom TY, Rao S, Ishizuka K, Wong P, Korth C, Anton ES, Sawa A (2010) Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci USA 107:5622–5627CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Abazyan S, Yang EJ, Abazyan B, Xia M, Yang C, Rojas C, Slusher B, Sattler R, Pletnikov M (2014) Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism. J Neurosci Res 92:1659–1668CrossRefPubMedPubMedCentral Abazyan S, Yang EJ, Abazyan B, Xia M, Yang C, Rojas C, Slusher B, Sattler R, Pletnikov M (2014) Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism. J Neurosci Res 92:1659–1668CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Katsel P, Tan W, Abazyan B, Davis KL, Ross C, Pletnikov MV, Haroutunian V (2011) Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr Res 130:238–249CrossRefPubMedPubMedCentral Katsel P, Tan W, Abazyan B, Davis KL, Ross C, Pletnikov MV, Haroutunian V (2011) Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr Res 130:238–249CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, Yamada K, Takamura H, Matsuzaki S, Katayama T, Tohyama M, Ito A (2014) DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One 9:e88506CrossRefPubMedPubMedCentral Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, Yamada K, Takamura H, Matsuzaki S, Katayama T, Tohyama M, Ito A (2014) DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One 9:e88506CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sprooten E, Sussmann JE, Moorhead TW, Whalley HC, Ffrench-Constant C, Blumberg HP, Bastin ME, Hall J, Lawrie SM, McIntosh AM (2011) Association of white matter integrity with genetic variation in an exonic DISC1 SNP. Mol Psychiatry 16(685):688–689CrossRef Sprooten E, Sussmann JE, Moorhead TW, Whalley HC, Ffrench-Constant C, Blumberg HP, Bastin ME, Hall J, Lawrie SM, McIntosh AM (2011) Association of white matter integrity with genetic variation in an exonic DISC1 SNP. Mol Psychiatry 16(685):688–689CrossRef
37.
Zurück zum Zitat Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 47:1–13CrossRef Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 47:1–13CrossRef
38.
Zurück zum Zitat Whalley HC, Dimitrova R, Sprooten E, Dauvermann MR, Romaniuk L, Duff B, Watson AR, Moorhead B, Bastin M, Semple SI, Giles S, Hall J, Thomson P, Roberts N, Hughes ZA, Brandon NJ, Dunlop J, Whitcher B, Blackwood DH, McIntosh AM, Lawrie SM (2015) Effects of a balanced translocation between chromosomes 1 and 11 disrupting the DISC1 locus on white matter integrity. PLoS One 10:e0130900 (eCollection 2015) CrossRefPubMedPubMedCentral Whalley HC, Dimitrova R, Sprooten E, Dauvermann MR, Romaniuk L, Duff B, Watson AR, Moorhead B, Bastin M, Semple SI, Giles S, Hall J, Thomson P, Roberts N, Hughes ZA, Brandon NJ, Dunlop J, Whitcher B, Blackwood DH, McIntosh AM, Lawrie SM (2015) Effects of a balanced translocation between chromosomes 1 and 11 disrupting the DISC1 locus on white matter integrity. PLoS One 10:e0130900 (eCollection 2015) CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Burns J, Job D, Whalley H, Macgillivray T, Johnstone EC, Lawrie SM (2003) Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry 182:439–443CrossRef Burns J, Job D, Whalley H, Macgillivray T, Johnstone EC, Lawrie SM (2003) Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry 182:439–443CrossRef
40.
Zurück zum Zitat Spalletta G, Tomaiuolo F, Marino V, Bonaviri G, Trequattrini A, Caltagirone C (2003) Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophr Res 64:15–23CrossRefPubMed Spalletta G, Tomaiuolo F, Marino V, Bonaviri G, Trequattrini A, Caltagirone C (2003) Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophr Res 64:15–23CrossRefPubMed
41.
Zurück zum Zitat Mitelman SA, Buchsbaum MS, Brickman AM, Shihabuddin L (2005) Cortical intercorrelations of frontal area volumes in schizophrenia. Neuroimage 27:753–770CrossRefPubMed Mitelman SA, Buchsbaum MS, Brickman AM, Shihabuddin L (2005) Cortical intercorrelations of frontal area volumes in schizophrenia. Neuroimage 27:753–770CrossRefPubMed
42.
Zurück zum Zitat Mitelman SA, Brickman AM, Shihabuddin L, Newmark RE, Hazlett EA, Haznedar MM, Buchsbaum MS (2007) A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 37:449–462CrossRefPubMedPubMedCentral Mitelman SA, Brickman AM, Shihabuddin L, Newmark RE, Hazlett EA, Haznedar MM, Buchsbaum MS (2007) A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 37:449–462CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Kyriakopoulos M, Frangou S (2009) Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 22:168–176CrossRefPubMed Kyriakopoulos M, Frangou S (2009) Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 22:168–176CrossRefPubMed
44.
Zurück zum Zitat Baumann B, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R, Wurthmann C, Bernstein HG, Bogerts B (1999) Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci 11:71–78CrossRefPubMed Baumann B, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R, Wurthmann C, Bernstein HG, Bogerts B (1999) Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci 11:71–78CrossRefPubMed
45.
Zurück zum Zitat Bernstein HG, Stricker R, Lendeckel U, Bertram I, Dobrowolny H, Steiner J, Bogerts B, Reiser G (2009) Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer’s disease and Down syndrome brains. Age (Dordr) 31:11–25CrossRef Bernstein HG, Stricker R, Lendeckel U, Bertram I, Dobrowolny H, Steiner J, Bogerts B, Reiser G (2009) Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer’s disease and Down syndrome brains. Age (Dordr) 31:11–25CrossRef
46.
Zurück zum Zitat Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28:655–662CrossRefPubMed Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH (1999) Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28:655–662CrossRefPubMed
47.
Zurück zum Zitat Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867–875CrossRefPubMed Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867–875CrossRefPubMed
48.
Zurück zum Zitat Vázquez-Bourgon J, Mata I, Roiz-Santiáñez R, Ayesa-Arriola R, Suárez Pinilla P, Tordesillas-Gutiérrez D, Vázquez-Barquero JL, Crespo-Facorro B (2014) Disrupted-in-Schizophrenia 1 gene variant is associated with clinical symptomatology in patients with first-episode psychosis. Psychiatry Investig 11:186–191CrossRefPubMedPubMedCentral Vázquez-Bourgon J, Mata I, Roiz-Santiáñez R, Ayesa-Arriola R, Suárez Pinilla P, Tordesillas-Gutiérrez D, Vázquez-Barquero JL, Crespo-Facorro B (2014) Disrupted-in-Schizophrenia 1 gene variant is associated with clinical symptomatology in patients with first-episode psychosis. Psychiatry Investig 11:186–191CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Szeszko PR, Hodgkinson CA, Robinson DG, Derosse P, Bilde RM, Lencz T, Burdick KE, Napolitano B, Betensky JD, Kane JM, Goldman D, Malhotra AK (2008) DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol 79:103–110CrossRefPubMed Szeszko PR, Hodgkinson CA, Robinson DG, Derosse P, Bilde RM, Lencz T, Burdick KE, Napolitano B, Betensky JD, Kane JM, Goldman D, Malhotra AK (2008) DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol 79:103–110CrossRefPubMed
50.
Zurück zum Zitat Goudriaan A, de Leeuw C, Ripke S, Hultman CM, Sklar P, Sullivan PF, Smit AB, Posthuma D, Verheijen MH (2014) Specific glial functions contribute to schizophrenia susceptibility. Schizophr Bull 40:925–935CrossRefPubMed Goudriaan A, de Leeuw C, Ripke S, Hultman CM, Sklar P, Sullivan PF, Smit AB, Posthuma D, Verheijen MH (2014) Specific glial functions contribute to schizophrenia susceptibility. Schizophr Bull 40:925–935CrossRefPubMed
51.
Zurück zum Zitat Martins-de-Souza D (2010) Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiatr Res 44:149–156CrossRefPubMed Martins-de-Souza D (2010) Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiatr Res 44:149–156CrossRefPubMed
52.
Zurück zum Zitat Le Hellard S, Mühleisen TW, Djurovic S, Fernø J, Ouriaghi Z, Mattheisen M, Vasilescu C, Raeder MB, Hansen T, Strohmaier J, Georg A, Brockschmidt FF, Melle I, Nenadic I, Sauer H, Rietschel M, Nöthen MM, Werge T, Andreassen OA, Cichon S, Steen VM (2010) Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry 15:463–472CrossRefPubMed Le Hellard S, Mühleisen TW, Djurovic S, Fernø J, Ouriaghi Z, Mattheisen M, Vasilescu C, Raeder MB, Hansen T, Strohmaier J, Georg A, Brockschmidt FF, Melle I, Nenadic I, Sauer H, Rietschel M, Nöthen MM, Werge T, Andreassen OA, Cichon S, Steen VM (2010) Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry 15:463–472CrossRefPubMed
53.
Zurück zum Zitat Hakak Y, Walker JR, Li C, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746–4751CrossRefPubMedPubMedCentral Hakak Y, Walker JR, Li C, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746–4751CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE, Lipska BK (2008) Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 98:129–138CrossRefPubMed Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE, Lipska BK (2008) Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 98:129–138CrossRefPubMed
55.
Zurück zum Zitat Takahashi N, Sakurai T (2013) Roles of glial cells in schizophrenia: possible targets for therapeutic approaches. Neurobiol Dis 53:49–60CrossRefPubMed Takahashi N, Sakurai T (2013) Roles of glial cells in schizophrenia: possible targets for therapeutic approaches. Neurobiol Dis 53:49–60CrossRefPubMed
56.
Zurück zum Zitat Saia-Cereda VM, Cassoli JS, Schmitt A, Falkai P, Nascimento JM, Martins-de-Souza D (2015) Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-015-0621-1 Saia-Cereda VM, Cassoli JS, Schmitt A, Falkai P, Nascimento JM, Martins-de-Souza D (2015) Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-015-0621-1
57.
Zurück zum Zitat Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, Haroutunian V (2008) Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 33:2993–3009CrossRefPubMed Katsel P, Davis KL, Li C, Tan W, Greenstein E, Kleiner Hoffman LB, Haroutunian V (2008) Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 33:2993–3009CrossRefPubMed
58.
Zurück zum Zitat Ratta-Apha W, Hishimoto A, Mouri K, Shiroiwa K, Sasada T, Yoshida M, Supriyanto I, Ueno Y, Asano M, Shirakawa O, Togashi H, Takai Y, Sora I (2013) Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain. Neurosci Res 77:222–227CrossRefPubMed Ratta-Apha W, Hishimoto A, Mouri K, Shiroiwa K, Sasada T, Yoshida M, Supriyanto I, Ueno Y, Asano M, Shirakawa O, Togashi H, Takai Y, Sora I (2013) Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain. Neurosci Res 77:222–227CrossRefPubMed
59.
Zurück zum Zitat Trossbach SV, Fehsel K, Henning U, Winterer G, Luckhaus C, Schäble S, Silva MA, Korth C (2014) Peripheral DISC1 protein levels as a trait marker for schizophrenia and modulating effects of nicotine. Behav Brain Res 275:176–182CrossRefPubMed Trossbach SV, Fehsel K, Henning U, Winterer G, Luckhaus C, Schäble S, Silva MA, Korth C (2014) Peripheral DISC1 protein levels as a trait marker for schizophrenia and modulating effects of nicotine. Behav Brain Res 275:176–182CrossRefPubMed
60.
Zurück zum Zitat Nakata K, Lipska BK, Hyde TM, Ye T, Newburn EN, Morita Y, Vakkalanka R, Barenboim M, Sei Y, Weinberger DR, Kleinman JE (2009) DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 106:15873–15878CrossRefPubMedPubMedCentral Nakata K, Lipska BK, Hyde TM, Ye T, Newburn EN, Morita Y, Vakkalanka R, Barenboim M, Sei Y, Weinberger DR, Kleinman JE (2009) DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 106:15873–15878CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Oliney A, House R, Gao B, Recksiek P, Phang TL, Sullivan B, Hollis JP, Hopkins J, Shade T, Edwards MG, Vianzon R, Griffith C, Ceilley J, Helfrisch RW, Ritvo Weis E, Weiss D, Gault J (2011) Elevated DISC1 transcript levels in PBMs during acute psychosis in patients with schizophrenia. Transl Biomed 2(1):9 Oliney A, House R, Gao B, Recksiek P, Phang TL, Sullivan B, Hollis JP, Hopkins J, Shade T, Edwards MG, Vianzon R, Griffith C, Ceilley J, Helfrisch RW, Ritvo Weis E, Weiss D, Gault J (2011) Elevated DISC1 transcript levels in PBMs during acute psychosis in patients with schizophrenia. Transl Biomed 2(1):9
62.
Zurück zum Zitat Santoro ML, Gadelha A, Ota VK, Cunha GR, Asevedo E, Noto CS, Spindola LM, Pan PM, Talarico F, Mansur RB, Silva PN, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI (2015) Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls. World J Biol Psychiatry 18:1–6 (Epub ahead of print) Santoro ML, Gadelha A, Ota VK, Cunha GR, Asevedo E, Noto CS, Spindola LM, Pan PM, Talarico F, Mansur RB, Silva PN, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI (2015) Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls. World J Biol Psychiatry 18:1–6 (Epub ahead of print)
63.
Zurück zum Zitat Soares DC, Carlyle BC, Bradshaw NJ, Porteous DJ (2011) DISC1: structure, function, and therapeutic potential for major mental illness. ACS Chem Neurosci 2:609–632CrossRefPubMedPubMedCentral Soares DC, Carlyle BC, Bradshaw NJ, Porteous DJ (2011) DISC1: structure, function, and therapeutic potential for major mental illness. ACS Chem Neurosci 2:609–632CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Bernstein HG, Stürze E, Bogerts B (2010) Cell cycle disturbances in schizophrenia: the journey so far. Acta Clin Croat 49(Suppl 1):33–35 Bernstein HG, Stürze E, Bogerts B (2010) Cell cycle disturbances in schizophrenia: the journey so far. Acta Clin Croat 49(Suppl 1):33–35
65.
Zurück zum Zitat Ren Y, Wang Y, Xiao L (2013) Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? Int J Neuropsychopharmacol 16:691–700CrossRefPubMed Ren Y, Wang Y, Xiao L (2013) Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? Int J Neuropsychopharmacol 16:691–700CrossRefPubMed
66.
Zurück zum Zitat Chiba S, Hashimoto R, Hattori S, Yohda M, Lipska B, Weinberger DR, Kunugi H (2006) Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 113:1337–1346CrossRefPubMed Chiba S, Hashimoto R, Hattori S, Yohda M, Lipska B, Weinberger DR, Kunugi H (2006) Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 113:1337–1346CrossRefPubMed
67.
Zurück zum Zitat Nagai T, Kitahara Y, Ibi D, Nabeshima T, Sawa A, Yamada K (2011) Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal poly I: c treatment. Behav Brain Res 225:305–310CrossRefPubMed Nagai T, Kitahara Y, Ibi D, Nabeshima T, Sawa A, Yamada K (2011) Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal poly I: c treatment. Behav Brain Res 225:305–310CrossRefPubMed
68.
Zurück zum Zitat Mai JK, Paxinos G, Voss T (1997) Atlas of the Human Brain. Academic Press, New York Mai JK, Paxinos G, Voss T (1997) Atlas of the Human Brain. Academic Press, New York
Metadaten
Titel
Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia
verfasst von
Hans-Gert Bernstein
Esther Jauch
Henrik Dobrowolny
Christian Mawrin
Johann Steiner
Bernhard Bogerts
Publikationsdatum
28.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 6/2016
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-015-0640-y

Weitere Artikel der Ausgabe 6/2016

European Archives of Psychiatry and Clinical Neuroscience 6/2016 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.